Xconomy National

Archives

by in
Entry Author Date Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups Luke Timmerman 12/22/11 Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech Arlene Weintraub 10/27/11 New York
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News Luke Timmerman 10/20/11 Seattle
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question Luke Timmerman 10/19/11 Seattle
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine Arlene Weintraub 10/18/11 Boston
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader Luke Timmerman 09/13/11 Seattle
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed Luke Timmerman 07/20/11 Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig Luke Timmerman 06/27/11 Seattle
PATH Partners With GSK on Malaria Vaccine Luke Timmerman 06/06/11 Seattle
From Three-Month Ice to Fast Broadband Everywhere: Some Projects You Might Not Know About From Intellectual Ventures Lab Curt Woodward 04/21/11 Seattle
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies Luke Timmerman 03/08/11 Seattle
Pfēnex Awarded $3.1M for Malaria Work Bruce V. Bigelow 01/26/11 San Diego
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29 Luke Timmerman 11/09/10 Seattle
Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health Luke Timmerman 07/30/10 Seattle
How Seattle Startups Could Lead the World: Five Technology Themes to Watch Gregory T. Huang 06/18/10 Seattle
Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain Ryan McBride 05/20/10 Boston
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News Luke Timmerman 05/20/10 Seattle
Seattle BioMed Starts Malaria Trial Luke Timmerman 05/13/10 Seattle
Genocea Gets $2.7M for Malaria Vaccine Luke Timmerman 04/15/10 Boston
Beaming Power to UAVs, Space Elevators, and Someday, Earth: The LaserMotive Plan Gregory T. Huang 04/13/10 Seattle
The Dendreon Alumni Directory, Sage Snags Merck Deal, Adaptive TCR Nabs $4.5M & More Seattle-Area Life Sciences News Luke Timmerman 04/01/10 Seattle
Nine Years in the Making, Seattle BioMed’s Malaria Vaccine On Verge of First Human Trial Luke Timmerman 03/26/10 Seattle
U.S. Chief Humanitarian: We Want to Buy Your Health Products For Poor Countries Luke Timmerman 03/17/10 Seattle
Una Ryan Searching for Riches to Deliver Inexpensive Diagnostics to the Poor Ryan McBride 03/05/10 Boston
Bill Gates Posts Annual Letter, Backs Khosla Gregory T. Huang 01/25/10 Seattle
Genomics Laid the Foundation for Big Global Health Advances To Come This Decade Ken Stuart 01/21/10 Seattle
The Intellectual Property Century Steve Davis 01/11/10 National
FDA Approves Over-the-Counter Version of Santarus Drug, Pioneer of Algal Biofuels Says Algae Will Make Drugs Too, Receptos Gets $25M, & More San Diego Life Sciences News Bruce V. Bigelow 12/02/09 San Diego
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic Luke Timmerman 11/03/09 Seattle
Vaccine Exec Named SBRI Chair Luke Timmerman 10/01/09 Seattle
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.